Board Meeting22 May 2026, 04:51 pm
Welcure Drugs Board Meeting on May 29, 2026
AI Summary
Welcure Drugs & Pharmaceuticals Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the audited financial results for the quarter/year ended March 31, 2026. The board will also review the audit report from the statutory auditors and approve the audited financial statements, including the balance sheet, profit and loss statement, and cash flow statement for the same period.
Key Highlights
- Board meeting scheduled for May 29, 2026.
- Audited financial results for the quarter/year ended March 31, 2026, to be considered.
- Audit report of the statutory auditors to be taken on record.
- Audited financial statements for the year ended March 31, 2026, to be approved.
Price Impact
More from WELCURE